23.10.2014 Views

Burns injury - PACT - ESICM

Burns injury - PACT - ESICM

Burns injury - PACT - ESICM

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Non-nutritional modulation of metabolism<br />

Decreasing the loss of lean body mass requires a multimodal approach that includes<br />

nursing in a warm environment (28-32°C) particularly during surgery and in case of<br />

open wound therapy, early surgical debridement and grafting, appropriate analgesia<br />

and sedation, pharmacological attenuation of the hypermetabolic response, and<br />

stimulation of anabolism.<br />

Propranolol, by attenuating the sympathetic response and its non-selective metabolic<br />

beta-2 blocking actions, strongly reduces catabolism and reduces cardiac work load<br />

in children and adults. Anabolic agents, such as insulin and oxandrolone, accelerate<br />

wound healing and shorten hospital stay. Oxandrolone started within 7 days of <strong>injury</strong><br />

has been shown to improve long term outcome in both adults and children in<br />

prospective randomised trials. Recombinant growth hormone (GH) probably has its<br />

place in the treatment of children (but not in adult burns patients) as children with<br />

burn injuries have a proven GH deficit.<br />

Wolf SE, Edelman LS, Kemalyan N, Donison L, Cross J, Underwood M, et al.<br />

Effects of oxandrolone on outcome measures in the severely burned: a<br />

multicenter prospective randomized double-blind trial.J Burn Care Res<br />

2006;27(2): 131–139; discussion 140-141. PMID 16566555<br />

Patients with large burns are strongly catabolic, and weight loss is<br />

considerable; this response can be reduced by beta-blockade and liberal protein<br />

supply.<br />

Williams FN, Herndon DN, Kulp GA, Jeschke MG. Propranolol decreases cardiac<br />

work in a dose-dependent manner in severely burned children. Surgery<br />

2011; 149(2): 231–239. PMID 20598332<br />

Gauglitz GG, Williams FN, Herndon DN, Jeschke MG. <strong>Burns</strong>: where are we<br />

standing with propranolol, oxandrolone, recombinant human growth<br />

hormone, and the new incretin analogs? Curr Opin Clin Nutr Metab Care<br />

2011; 14(2): 176–181. PMID 21157309<br />

Jeschke MG, Finnerty CC, Kulp GA, Przkora R, Mlcak RP, Herndon DN.<br />

Combination of recombinant human growth hormone and propranolol<br />

decreases hypermetabolism and inflammation in severely burned<br />

children. Pediatr Crit Care Med 2008; 9(2): 209–216. PMID 18477935<br />

Porro LJ, Herndon DN, Rodriguez NA, Jennings K, Klein GL, Mlcak RP, et al.<br />

Five-year outcomes after oxandrolone administration in severely burned<br />

children: a randomized clinical trial of safety and efficacy. J Am Coll<br />

Surg 2012; 214(4): 489–502; discussion 502–504. PMID 22463890<br />

Pham TN, Klein MB, Gibran NS, Arnoldo BD, Gamelli RL, Silver GM, et al. Impact<br />

of oxandrolone treatment on acute outcomes after severe burn <strong>injury</strong>. J<br />

Burn Care Res 2008; 29(6): 902–906. PMID 18849836<br />

32

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!